OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
M Li, Xiaoli Yu
Oncogene (2014) Vol. 34, Iss. 26, pp. 3349-3356
Open Access | Times Cited: 95
M Li, Xiaoli Yu
Oncogene (2014) Vol. 34, Iss. 26, pp. 3349-3356
Open Access | Times Cited: 95
Showing 1-25 of 95 citing articles:
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 403
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 403
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
Seung Min Kim, Yoosoo Yang, Seung Ja Oh, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 8-16
Closed Access | Times Cited: 401
Seung Min Kim, Yoosoo Yang, Seung Ja Oh, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 8-16
Closed Access | Times Cited: 401
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions
И. Ф. Беленичев, Olena Popazova, Nina Bukhtiyarova, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 108-108
Open Access | Times Cited: 2
И. Ф. Беленичев, Olena Popazova, Nina Bukhtiyarova, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 108-108
Open Access | Times Cited: 2
A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors
Lior Izhar, Britt Adamson, Alberto Ciccia, et al.
Cell Reports (2015) Vol. 11, Iss. 9, pp. 1486-1500
Open Access | Times Cited: 161
Lior Izhar, Britt Adamson, Alberto Ciccia, et al.
Cell Reports (2015) Vol. 11, Iss. 9, pp. 1486-1500
Open Access | Times Cited: 161
PARP2 mediates branched poly ADP-ribosylation in response to DNA damage
Qian Chen, Muzaffer Ahmad Kassab, Françoise Dantzer, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Qian Chen, Muzaffer Ahmad Kassab, Françoise Dantzer, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y. Feng, Johann S. de Bono, Mark A. Rubin, et al.
Molecular Cell (2015) Vol. 58, Iss. 6, pp. 925-934
Open Access | Times Cited: 132
Felix Y. Feng, Johann S. de Bono, Mark A. Rubin, et al.
Molecular Cell (2015) Vol. 58, Iss. 6, pp. 925-934
Open Access | Times Cited: 132
Management of relapsed ovarian cancer: a review
Gonzalo Giornelli
SpringerPlus (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 119
Gonzalo Giornelli
SpringerPlus (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 119
Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
Paul Lesueur, François Chevalier, Jean-Baptiste Austry, et al.
Oncotarget (2017) Vol. 8, Iss. 40, pp. 69105-69124
Open Access | Times Cited: 116
Paul Lesueur, François Chevalier, Jean-Baptiste Austry, et al.
Oncotarget (2017) Vol. 8, Iss. 40, pp. 69105-69124
Open Access | Times Cited: 116
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma
José Mario González-Meljem, Scott Haston, Gabriela Carreno, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 102
José Mario González-Meljem, Scott Haston, Gabriela Carreno, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 102
PARP Trapping Beyond Homologous Recombination and Platinum Sensitivity in Cancers
Junko Murai, Yves Pommier
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 131-150
Closed Access | Times Cited: 95
Junko Murai, Yves Pommier
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 131-150
Closed Access | Times Cited: 95
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma
Shaofang Wu, Xiaolong Li, Feng Gao, et al.
Neuro-Oncology (2021) Vol. 23, Iss. 6, pp. 920-931
Open Access | Times Cited: 93
Shaofang Wu, Xiaolong Li, Feng Gao, et al.
Neuro-Oncology (2021) Vol. 23, Iss. 6, pp. 920-931
Open Access | Times Cited: 93
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma
Valeria Colicchia, Marialaura Petroni, Giulia Guarguaglini, et al.
Oncogene (2017) Vol. 36, Iss. 33, pp. 4682-4691
Closed Access | Times Cited: 92
Valeria Colicchia, Marialaura Petroni, Giulia Guarguaglini, et al.
Oncogene (2017) Vol. 36, Iss. 33, pp. 4682-4691
Closed Access | Times Cited: 92
CREBBP and p300 lysine acetyl transferases in the DNA damage response
Ilaria Dutto, Claudia Scalera, Ennio Prosperi
Cellular and Molecular Life Sciences (2017) Vol. 75, Iss. 8, pp. 1325-1338
Open Access | Times Cited: 92
Ilaria Dutto, Claudia Scalera, Ennio Prosperi
Cellular and Molecular Life Sciences (2017) Vol. 75, Iss. 8, pp. 1325-1338
Open Access | Times Cited: 92
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study
Patricia Baxter, Jack M. Su, Arzu Onar‐Thomas, et al.
Neuro-Oncology (2020) Vol. 22, Iss. 6, pp. 875-885
Open Access | Times Cited: 71
Patricia Baxter, Jack M. Su, Arzu Onar‐Thomas, et al.
Neuro-Oncology (2020) Vol. 22, Iss. 6, pp. 875-885
Open Access | Times Cited: 71
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 12
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 12
New directions in poly(ADP‐ribose) polymerase biology
Florian J. Bock, Paul Chang
FEBS Journal (2016) Vol. 283, Iss. 22, pp. 4017-4031
Open Access | Times Cited: 77
Florian J. Bock, Paul Chang
FEBS Journal (2016) Vol. 283, Iss. 22, pp. 4017-4031
Open Access | Times Cited: 77
Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma
Giuseppe Carlucci, Brandon Carney, Christian Brand, et al.
Molecular Imaging and Biology (2015) Vol. 17, Iss. 6, pp. 848-855
Open Access | Times Cited: 72
Giuseppe Carlucci, Brandon Carney, Christian Brand, et al.
Molecular Imaging and Biology (2015) Vol. 17, Iss. 6, pp. 848-855
Open Access | Times Cited: 72
The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges
Μaria Dalamaga, Gerasimos Socrates Christodoulatos, Christos S. Mantzoros
Metabolism (2018) Vol. 82, pp. 72-87
Closed Access | Times Cited: 71
Μaria Dalamaga, Gerasimos Socrates Christodoulatos, Christos S. Mantzoros
Metabolism (2018) Vol. 82, pp. 72-87
Closed Access | Times Cited: 71
Combining PARP Inhibition, Radiation, and Immunotherapy: A Possible Strategy to Improve the Treatment of Cancer?
Mathieu Césaire, Juliette Thariat, Serge M. Candéias, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3793-3793
Open Access | Times Cited: 71
Mathieu Césaire, Juliette Thariat, Serge M. Candéias, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3793-3793
Open Access | Times Cited: 71
Aberrations in DNA repair pathways in cancer and therapeutic significances
Akira Motegi, Mitsuko Masutani, Kenichi Yoshioka, et al.
Seminars in Cancer Biology (2019) Vol. 58, pp. 29-46
Closed Access | Times Cited: 70
Akira Motegi, Mitsuko Masutani, Kenichi Yoshioka, et al.
Seminars in Cancer Biology (2019) Vol. 58, pp. 29-46
Closed Access | Times Cited: 70
Evaluation of Rucaparib and Companion Diagnostics in the PARP Inhibitor Landscape for Recurrent Ovarian Cancer Therapy
Zachary B. Jenner, Anil K. Sood, Robert L. Coleman
Future Oncology (2016) Vol. 12, Iss. 12, pp. 1439-1456
Open Access | Times Cited: 69
Zachary B. Jenner, Anil K. Sood, Robert L. Coleman
Future Oncology (2016) Vol. 12, Iss. 12, pp. 1439-1456
Open Access | Times Cited: 69
Bacterial Genotoxin-Induced DNA Damage and Modulation of the Host Immune Microenvironment
Océane Martin, Teresa Frisan
Toxins (2020) Vol. 12, Iss. 2, pp. 63-63
Open Access | Times Cited: 53
Océane Martin, Teresa Frisan
Toxins (2020) Vol. 12, Iss. 2, pp. 63-63
Open Access | Times Cited: 53
SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage
Karla F. Meza‐Sosa, Rui Miao, Francisco Navarro, et al.
Molecular Cell (2022) Vol. 82, Iss. 4, pp. 785-802.e10
Open Access | Times Cited: 37
Karla F. Meza‐Sosa, Rui Miao, Francisco Navarro, et al.
Molecular Cell (2022) Vol. 82, Iss. 4, pp. 785-802.e10
Open Access | Times Cited: 37
PARP inhibitors combined with radiotherapy: are we ready?
Chen Sun, Alan Chu, Rui Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Chen Sun, Alan Chu, Rui Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
